Table 3. Table 3 provides the incidence of delirium and secondary outcomes in the 4 groups in the study namely propofol, propofol + acemaninophen, dexmedetomidine, dexmedetomidine + acetaminophen.
| Propofol | Propofol +
Acetaminophen |
Dexmedetomidine | Dexmedetomidine +
Acetaminophen |
|
|---|---|---|---|---|
|
Incidence of Delirium
% (n/N) |
66.6 (2/3) | 0 (2/3) | 66.6 (2/3) | 33.3 (1/3) |
|
Mean Delirium duration
[n days] |
1 | 0 | 1 | 1 |
|
Opioid consumption
mean [SD] * |
2.84 [1.95] | 2.63 [2.2] | 5.24 [5.3] | 2.4 [2.2] |
|
Time to extubation (mins)
mean [SD] |
213.67 [42.83] | 607.67 [371.66] | 486.67 [278.55] | 391.33 [242.43] |
|
Length of stay (days)
mean [SD] |
6 [0] | 5.33 [1.15] | 6.67 [3.06] | 10.33 [9.29] |
| Adverse events | 0 | 0 | 0 | 1 |
*Opioid consumption is expressed in hydromorphone equivalent